RegWardenFDA facility compliance records
Facility

Ortho-Clinical Diagnostics Singapore Pte Ltd

1 recall(s) on record — most severe on record: Class II.

Activity by year

FDA actions on record by year2024: 1 recalls20172018201920202021202220231202420252026
  • Recalls (1)

Devices registered here (2)

  • Radioimmunoassay, Follicle-Stimulating Hormone
    Product code CGJ (opens in a new tab) · Class I · Clinical Chemistry · 21 CFR 862.1300
  • Calibrator, Primary
    Product code JIS (opens in a new tab) · Class II · Clinical Chemistry · 21 CFR 862.1150

Recalls & enforcement

  • Class IIOngoing2024-04-09
    T3 Reagent Packs used with Free T3 Calibrators may produce positively biased results for patient and quality control samples. The positive bias may cause erroneous patient results or a delay in testing that may impact patient management, clinical assessment, and the results of ot…

Related

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Ortho-Clinical Diagnostics Singapore Pte Ltd (FEI 3002642396) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3002642396-ortho-clinical-diagnostics-singapore-pte/

Not open yet

Alerts for Ortho-Clinical Diagnostics Singapore Pte Ltd

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.